Stay updated on ECHO-204 Clinical Trial: Epacadostat + Nivolumab
Sign up to get notified when there's something new on the ECHO-204 Clinical Trial: Epacadostat + Nivolumab page.

Latest updates to the ECHO-204 Clinical Trial: Epacadostat + Nivolumab page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page’s displayed software/browser revision marker was updated from v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check17 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check24 days agoNo Change Detected
- Check45 days agoChange DetectedRevision tag updated from v3.4.3 to v3.5.0. There are no visible changes to study details or page layout.SummaryDifference0.0%

- Check60 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check82 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2; there are no changes to study content, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check89 days agoChange DetectedThe page now shows Revision: v3.4.1, replacing the previous Revision: v3.4.0.SummaryDifference0.0%

Stay in the know with updates to ECHO-204 Clinical Trial: Epacadostat + Nivolumab
Enter your email address, and we'll notify you when there's something new on the ECHO-204 Clinical Trial: Epacadostat + Nivolumab page.